首页|期刊导航|中国中医药信息杂志|基于网络药理学和动物实验探讨生腺布液汤治疗干燥综合征的作用机制

基于网络药理学和动物实验探讨生腺布液汤治疗干燥综合征的作用机制OA

Exploration on the Mechanism of Shengxian Buye Decoction in Treating Sjögren's Syndrome Based on Network Pharmacology and Animal Experiments

中文摘要英文摘要

目的 采用网络药理学方法探讨生腺布液汤治疗干燥综合征(SS)的作用机制,并进行动物实验验证.方法 利用TCMSP、HERB、TCMID数据库检索并筛选生腺布液汤活性成分及其相应靶点,通过药物-成分-靶点网络获取核心成分,利用GeneCards、OMIM、TTD、PharmGKB、DrugBank数据库检索SS疾病靶点,将药物与疾病交集靶点作为生腺布液汤治疗SS潜在靶点,构建蛋白相互作用网络并筛选核心靶点,对交集靶点进行GO和KEGG通路富集分析.将24只SS模型NOD小鼠随机分为中药组、西药组和模型组,每组8只,另取8只BALB/c小鼠为正常组,分别予9.88 g/kg生腺布液汤、0.052 g/kg硫酸羟氯喹溶液及等体积蒸馏水灌胃,连续8周.记录小鼠第1、4、8周饮水量,HE染色观察小鼠颌下腺组织形态,ELISA检测血清IL-6、TNF-α含量,Western blot检测颌下腺组织PI3K-Akt通路蛋白表达.结果 网络药理学筛选得到生腺布液汤治疗SS的前7位核心成分为槲皮素、山柰酚、木犀草素、β-谷甾醇、豆甾醇、芒柄花素、汉黄芩素,潜在靶点共101个,前5位关键靶点为IL6、IL1B、TNF、AKT1、MMP9,主要富集于PI3K-Akt、MAPK、TNF信号通路.动物实验结果显示,与模型组比较,第4、8周,中药组、西药组小鼠饮水量均减少(P<0.05),颌下腺组织中灶性淋巴样细胞聚集减少,血清IL-6、TNF-α含量明显降低(P<0.05),颌下腺组织p-PI3K、PI3K、p-AKT、AKT蛋白表达均上调(P<0.05).结论 生腺布液汤可能通过PI3K-Akt、MAPK、TNF信号通路等发挥抗炎、调节免疫作用,从而治疗SS.

Objective To explore the mechanism of Shengxian Buye Decoction in the treatment of Sjögren's syndrome(SS)using network pharmacology;To conduct animal experiments for validation.Methods TCMSP,HERB and TCMID databases were used to retrieve and screen the active components and corresponding targets of Shengxian Buye Decoction.The core components were obtained through the drug-component-target network,and the SS disease targets were retrieved from GeneCards,OMIM,TTD,PharmGKB,and DrugBank databases.The protein-protein interaction network was constructed and the core targets were screened.The intersection targets were enriched by GO and KEGG pathways.A total of 24 SS model NOD mice were randomly divided into the Chinese materia medica group,Western medicine group,and model group,with 8 mice in each group;another 8 BALB/c mice were selected as the normal group.The mice in each group were intragastrically administered with Shengxian Buye Decoction(9.88 g/kg),hydroxychloroquine sulfate solution(0.052 g/kg),and an equal volume of distilled water,respectively,for 8 consecutive weeks.The water intake was recorded at 1,4,and 8 weeks.HE staining was employed to observe the pathological changes of the submandibular gland tissue.ELISA was used to compare the serum levels of interleukin-6(IL-6)and tumor necrosis factor-α(TNF-α).Western blot was used to detect the protein expression of PI3K-Akt pathway.Results Through network pharmacology screening,the top 7 core active components of Shengxian Buye Decoction for treating SS were quercetin,kaempferol,luteolin,β-sitosterol,stigmasterol,formononetin and wogonin,with 101 corresponding therapeutic targets.The top 5 targets were IL6,IL1B,TNF,AKT1,and MMP9.These key targets were mainly enriched in the PI3K-Akt,MAPK,and TNF signaling pathways.Animal experiment results showed that,compared with the model group,the water intake of mice in the Chinese materia medica group and Western medicine group significantly decreased at 4 and 8 weeks after treatment(P<0.05);focal lymphoid cell aggregation in the submandibular gland tissue of mice decreased;the serum contents of inflammatory factors IL-6 and TNF-α were significantly reduced(P<0.05);the expressions of p-PI3K,PI3K,p-Akt,and Akt proteins of the submandibular gland were up-regulated(P<0.05).Conclusion Shengxian Buye Decoction may exert anti-inflammatory and immune-regulating effects to treat SS by regulating signaling pathways such as PI3K-Akt,MAPK,and TNF.

王金娥;张正国;刘龙霞;张寒;侯小双;罗亚萍;靳可心;张莹

河北中医药大学,河北 石家庄 050091邯郸市中医院,河北 邯郸 056001河北中医药大学,河北 石家庄 050091河北省胸科医院,河北 石家庄 050041河北中医药大学第一附属医院,河北 石家庄 050011河北中医药大学第一附属医院,河北 石家庄 050011河北中医药大学,河北 石家庄 050091河北中医药大学,河北 石家庄 050091

医药卫生

干燥综合征生腺布液汤网络药理学实验验证

Sjögren's syndromeShengxian Buye Decoctionnetwork pharmacologyexperimental Validation

《中国中医药信息杂志》 2026 (6)

38-45,8

河北省重点研发计划(192777123D)河北省老年病防治项目(2019064577)政府资助临床医学优秀人才项目(ZF2025296)

10.19879/j.cnki.1005-5304.202511626

评论